Cargando…
Exosomes-based particles as inhalable COVID-19 vaccines
Coronavirus disease 2019 (COVID-19), a severely spreading pandemic, has dramatically brought physiological and economical burdens to people. Although the injectable vaccines have some achievements for coronavirus defense, they still generate accompanied pain, untoward reaction and cannot take part i...
Autores principales: | Fan, Lu, Wang, Li, Wang, Xiaoju, Zhang, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031725/ http://dx.doi.org/10.1016/j.bmt.2023.01.003 |
Ejemplares similares
-
The Big Potential of Small Particles: Lipid-Based Nanoparticles and Exosomes in Vaccination
por: Shimon, Marina Ben, et al.
Publicado: (2022) -
The potential role of inhaled nitric oxide for postexposure chemoprophylaxis of COVID-19
por: AbdelMassih, Antoine, et al.
Publicado: (2021) -
Nasally inhaled therapeutics and vaccination for COVID‐19: Developments and challenges
por: Xi, Jinxiang, et al.
Publicado: (2021) -
Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
por: Wang, Ziqi, et al.
Publicado: (2022) -
Development of vaccines at the time of COVID-19
por: Almond, Jeffrey, et al.
Publicado: (2020)